C-Major Ltd
The prime cause of needlestick injuries is that the clinician's attention is and should be focused on the patient. Although there have been many attempts to produce retractable hypodermic devices, and devices to prevent needle-stick injuries, none of these devices has been adopted into widespread use within the NHS or the wider healthcare sector.
Market Research has show that:
1.) The requirement from clinicians is that in order to remove the possibility of post-use needle-stick injury the hypdermic device needs to automatically retract immediately upon withdrawal from the skin of the patient. The retraction mechanism needs to be triggered without any adjustment in hand position by the clinician.
2.) That such a device has to be made in mass production quantities at a price that is comparable to non-retracting devices that are in common use today.
3.) To make a substantial reduction in the number of needle-stick injuries requires a range of devices to be available that meets the above conditions including: a full range of syringes capable of use with a range of needle sizes, blood handling systems, cannulas, epidural devices etc.
No devices that meet all these criteria are currently available.
Mr Colin Burgess, a serial inventor, has designed a range of devices capable of meeting these criteria. A new company has now been formed to develop these designs into devices that are capable of being manufactured and supplied to the NHS. Although the company is at an early stage, sufficient data has been gathered to demonstrate the potential, and funds are now needed to develop these ideas into viable products.
For more information, please contact Mr Aubrey Dunford, Managing Director at aubrey@c-major.co.uk
